Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Anamed Inc.

Latest From Anamed Inc.

Anamed Inc.

While myopia is well served by laser vision correction techniques, using lasers to reshape the cornea is more technically challenging for hyperopia. For the 32 million hyperopic patients in the US, Anamed Inc. hopes to provide a new vision correction that is reversible, or "additive, not subtractive." Anamed's first product for vision correction is {PermaVision}, intracorneal lenses made of a proprietary biomaterial, for the treatment of myopia, presbyopia, astigmatism and hyperopia.
Medical Device

Refractive Surgery

For the ultimate in convenience, hundreds of thousands of nearsighted and farsighted patients are turning to refractive surgery, or surgical vision correction procedures that promise a permanent alternative to glasses. New companies that wish to grab a portion of the $12 billion US market for vision correction are avoiding the crowded and competitive excimer laser business, with technologies that treat patients that LASIK (laser in-situ keratomileusis) doesn't serve well.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Ophthalmic
  • Ophthalmic > Ophth. Surgery
  • Ophthalmic > Vision Correction
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Anamed Inc.
  • Senior Management
  • Adrian Koppes, COO
  • Contact Info
  • Anamed Inc.
    Phone: (949) 453-8667
    One Technology Drive, D-409
    Irvine, CA 92618